Wellington Management Group LLP Raises Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Wellington Management Group LLP grew its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 84.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 18,325,123 shares of the company's stock after buying an additional 8,400,208 shares during the period. Wellington Management Group LLP owned 11.08% of Option Care Health worth $425,143,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Murphy & Mullick Capital Management Corp bought a new position in Option Care Health in the 4th quarter worth $26,000. UMB Bank n.a. raised its stake in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares in the last quarter. Signaturefd LLC raised its stake in Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after buying an additional 1,005 shares in the last quarter. Quarry LP lifted its holdings in Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company's stock worth $107,000 after buying an additional 2,628 shares during the period. Finally, Blue Trust Inc. boosted its position in Option Care Health by 16.9% during the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after acquiring an additional 681 shares in the last quarter. Institutional investors own 98.05% of the company's stock.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.64% of the company's stock.

Remove Ads

Option Care Health Stock Down 4.0 %

OPCH stock traded down $1.40 during trading on Friday, hitting $33.54. 2,392,435 shares of the stock traded hands, compared to its average volume of 1,734,150. The stock has a market cap of $5.51 billion, a price-to-earnings ratio of 28.18, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The firm's 50 day moving average is $32.97 and its two-hundred day moving average is $28.51.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and increased their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. JPMorgan Chase & Co. raised their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Barrington Research lifted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. Finally, JMP Securities restated a "market outperform" rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Option Care Health presently has an average rating of "Moderate Buy" and a consensus target price of $33.00.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.